| NR3C1 |
NR3C1, GRL: Glucocorticoid receptor |
GCN5L2 |
GCN5L2, GCN5, HGCN5: General control of amino acid synthesis protein 5-like 2 |
12.980 |
Evidence |
|
| VTN |
VTN: Vitronectin precursor |
B2M |
B2M, CDABP0092, HDCMA22P: Beta-2-microglobulin precursor [Contains: Beta-2-micro |
12.980 |
Evidence |
|
| ESR1 |
ESR1, ESR, NR3A1: Estrogen receptor |
CREBBP |
CREBBP, CBP: CREB-binding protein |
12.980 |
Evidence |
|
| ESR1 |
ESR1, ESR, NR3A1: Estrogen receptor |
NR4A2 |
NR4A2, NOT, NURR1, TINUR: Orphan nuclear receptor NR4A2 |
12.980 |
Evidence |
|
| APOH |
APOH, B2G1: Beta-2-glycoprotein 1 precursor |
SERPINB13 |
SERPINB13, PI13: Serpin B13 |
12.980 |
Evidence |
|
| APOH |
APOH, B2G1: Beta-2-glycoprotein 1 precursor |
SERPINI1 |
SERPINI1, PI12: Neuroserpin precursor |
12.980 |
Evidence |
|
| APOH |
APOH, B2G1: Beta-2-glycoprotein 1 precursor |
PRSS1 |
PRSS1, TRP1, TRY1, TRYP1: Trypsin-1 precursor |
12.980 |
Evidence |
|
| SPINK1 |
SPINK1, PSTI: Pancreatic secretory trypsin inhibitor precursor |
CGA |
CGA: Glycoprotein hormones alpha chain precursor |
12.980 |
Evidence |
|
| PLG |
PLG: Plasminogen precursor |
CTSG |
CTSG: Cathepsin G precursor |
12.980 |
Evidence |
|
| PLG |
PLG: Plasminogen precursor |
PRSS1 |
PRSS1, TRP1, TRY1, TRYP1: Trypsin-1 precursor |
12.980 |
Evidence |
|
| C1R |
C1R: Complement C1r subcomponent precursor |
ELA2 |
ELA2: Leukocyte elastase precursor |
12.980 |
Evidence |
|
| F10 |
F10: Coagulation factor X precursor |
OXTR |
OXTR: Oxytocin receptor |
12.910 |
Evidence |
|
| F9 |
F9: Coagulation factor IX precursor |
ITGA2B |
ITGA2B, GP2B, ITGAB: Integrin alpha-IIb precursor |
12.910 |
Evidence |
|
| F9 |
F9: Coagulation factor IX precursor |
IGF2R |
IGF2R, MPRI: Cation-independent mannose-6-phosphate receptor precursor |
12.910 |
Evidence |
|
| UBE2V2 |
UBE2V2, MMS2, UEV2: Ubiquitin-conjugating enzyme E2 variant 2 |
TRIM33 |
TRIM33, KIAA1113, RFG7, TIF1G: E3 ubiquitin-protein ligase TRIM33 |
12.910 |
Evidence |
|
| DUSP2 |
DUSP2, PAC1: Dual specificity protein phosphatase 2 |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
12.910 |
Evidence |
|
| B2M |
B2M, CDABP0092, HDCMA22P: Beta-2-microglobulin precursor [Contains: Beta-2-micro |
CLEC2B |
CLEC2B, AICL, CLECSF2, IFNRG1: C-type lectin domain family 2 member B |
12.910 |
Evidence |
|
| PCNA |
PCNA: Proliferating cell nuclear antigen |
TAF9 |
AK6, AD-004, CGI-137: Adenylate kinase isoenzyme 6 |
12.910 |
Evidence |
|
| SH2D1A |
SH2D1A, DSHP, SAP: SH2 domain-containing protein 1A |
CD3E |
CD3E, T3E: T-cell surface glycoprotein CD3 epsilon chain precursor |
12.910 |
Evidence |
|
| PPP1R2 |
PPP1R2, IPP2: Protein phosphatase inhibitor 2 |
GSK3A |
GSK3A: Glycogen synthase kinase-3 alpha |
12.9 |
Evidence |
|
| RAC2 |
RAC2: Ras-related C3 botulinum toxin substrate 2 precursor |
VIL2 |
IPI00479359 |
12.870 |
Evidence |
|
| STAT4 |
STAT4: Signal transducer and activator of transcription 4 |
STAT3 |
|
12.870 |
Evidence |
|
| TDG |
TDG: G/T mismatch-specific thymine DNA glycosylase |
CDC23 |
CDC23: Cell division cycle protein 23 homolog |
12.840 |
Evidence |
|
| QARS |
QARS: Glutaminyl-tRNA synthetase |
RBM15 |
RBM15, OTT: Putative RNA-binding protein 15 |
12.840 |
Evidence |
|
| QARS |
QARS: Glutaminyl-tRNA synthetase |
SFRS10 |
SFRS10, TRA2B: Splicing factor, arginine/serine-rich 10 |
12.840 |
Evidence |
|